September 29, 2023
NOVO NORDISK INC. et al v. BECERRA et al
Case Number:
3:23-cv-20814
Court:
Nature of Suit:
Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision
Judge:
Firms
- Akin Gump
- Buttaci Leardi
- Carella Byrne
- Flitter Milz
- Green Savits
- King & Spalding
- Motley Rice
- Weissman & Mintz
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Center for American Progress
- National Association for the Advancement of Colored People
- Novo Nordisk A S
- Public Citizen Inc.
- UnidosUS
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 01, 2024
Novo Nordisk Loses Challenge To Medicare Drug Price Talks
Another challenge to a Medicare drug price negotiation program has failed after a New Jersey federal judge ruled once again that the program is voluntary and rejected claims that it violates the constitutional rights of pharmaceutical giant Novo Nordisk.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login